Masimo EBITDA 2012-2025 | MASI
Masimo annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Masimo EBITDA for the quarter ending September 30, 2025 was $0.093B, a 90.2% increase year-over-year.
- Masimo EBITDA for the twelve months ending September 30, 2025 was $-0.074B, a 131.64% decline year-over-year.
- Masimo 2024 annual EBITDA was $-0.162B, a 168.36% decline from 2023.
- Masimo 2023 annual EBITDA was $0.237B, a 31.88% decline from 2022.
- Masimo 2022 annual EBITDA was $0.348B, a 11.59% increase from 2021.
|
Masimo Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-162 |
| 2023 | $237 |
| 2022 | $348 |
| 2021 | $311 |
| 2020 | $285 |
| 2019 | $245 |
| 2018 | $229 |
| 2017 | $204 |
| 2016 | $453 |
| 2015 | $136 |
| 2014 | $116 |
| 2013 | $91 |
| 2012 | $95 |
| 2011 | $94 |
|
Masimo Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $93 |
| 2025-06-30 | $73 |
| 2025-03-31 | $87 |
| 2024-12-31 | $-327 |
| 2024-09-30 | $49 |
| 2024-06-30 | $53 |
| 2024-03-31 | $64 |
| 2023-12-31 | $67 |
| 2023-09-30 | $50 |
| 2023-06-30 | $55 |
| 2023-03-31 | $65 |
| 2022-12-31 | $153 |
| 2022-09-30 | $32 |
| 2022-06-30 | $93 |
| 2022-03-31 | $69 |
| 2021-12-31 | $87 |
| 2021-09-30 | $77 |
| 2021-06-30 | $74 |
| 2021-03-31 | $74 |
| 2020-12-31 | $73 |
| 2020-09-30 | $67 |
| 2020-06-30 | $69 |
| 2020-03-31 | $75 |
| 2019-12-31 | $67 |
| 2019-09-30 | $58 |
| 2019-06-30 | $58 |
| 2019-03-31 | $61 |
| 2018-12-31 | $59 |
| 2018-09-30 | $54 |
| 2018-06-30 | $57 |
| 2018-03-31 | $59 |
| 2017-12-31 | $50 |
| 2017-09-30 | $48 |
| 2017-06-30 | $49 |
| 2017-03-31 | $57 |
| 2016-12-31 | $330 |
| 2016-09-30 | $41 |
| 2016-06-30 | $41 |
| 2016-03-31 | $41 |
| 2015-12-31 | $41 |
| 2015-09-30 | $32 |
| 2015-06-30 | $32 |
| 2015-03-31 | $31 |
| 2014-12-31 | $36 |
| 2014-09-30 | $26 |
| 2014-06-30 | $21 |
| 2014-03-31 | $33 |
| 2013-12-31 | $16 |
| 2013-09-30 | $24 |
| 2013-06-30 | $26 |
| 2013-03-31 | $26 |
| 2012-12-31 | $25 |
| 2012-09-30 | $20 |
| 2012-06-30 | $25 |
| 2012-03-31 | $24 |
| 2011-12-31 | $22 |
| 2011-09-30 | $21 |
| 2011-06-30 | $24 |
| 2011-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.462B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.511B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $210.153B | 82.22 |
| IDEXX Laboratories (IDXX) | United States | $56.962B | 56.57 |
| Edwards Lifesciences (EW) | United States | $49.401B | 33.12 |
| IQVIA Holdings (IQV) | United States | $41.282B | 23.02 |
| Alcon (ALC) | Switzerland | $39.524B | 26.71 |
| Mettler-Toledo (MTD) | United States | $30.339B | 35.49 |
| DexCom (DXCM) | United States | $26.287B | 36.24 |
| STERIS (STE) | Ireland | $25.206B | 26.02 |
| Waters (WAT) | United States | $23.626B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.855B | 33.88 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.750B | 0.00 |
| Globus Medical (GMED) | United States | $12.644B | 26.54 |
| Penumbra (PEN) | United States | $12.627B | 88.83 |
| Glaukos (GKOS) | United States | $6.486B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.358B | 20.20 |
| Teleflex (TFX) | United States | $4.986B | 7.94 |
| TransMedics (TMDX) | United States | $4.684B | 55.49 |
| LivaNova (LIVN) | United Kingdom | $3.517B | 19.00 |
| Alphatec Holdings (ATEC) | United States | $3.365B | 0.00 |
| Veracyte (VCYT) | United States | $3.323B | 37.87 |
| Integer Holdings (ITGR) | United States | $2.954B | 13.87 |
| Elekta AB (EKTAY) | Sweden | $2.377B | 22.24 |
| Artivion (AORT) | United States | $2.101B | 96.41 |
| UFP Technologies (UFPT) | United States | $1.986B | 26.22 |
| Nihon Kohden (NHNKY) | Japan | $1.934B | 16.88 |
| PROCEPT BioRobotics (PRCT) | United States | $1.834B | 0.00 |
| AxoGen (AXGN) | United States | $1.546B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.471B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 59.97 |
| Integra LifeSciences Holdings (IART) | United States | $1.058B | 5.73 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.982B | 0.00 |
| SiBone (SIBN) | United States | $0.887B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.887B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.675B | 39.27 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.625B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.588B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.459B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.448B | 12.38 |
| ClearPoint Neuro (CLPT) | United States | $0.424B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.296B | 2.21 |
| CVRx (CVRX) | United States | $0.213B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.162B | 0.00 |
| Neuronetics (STIM) | United States | $0.142B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.141B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Solana (HSDT) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.09 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |